洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR2000039791】Increasing rotavirus vaccine uptake: a randomised controlled trial

基本信息
登记号

ChiCTR2000039791

试验状态

正在进行

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2020-11-10

临床申请受理号

/

靶点

/

适应症

Rotavirus

试验通俗题目

Increasing rotavirus vaccine uptake: a randomised controlled trial

试验专业题目

Increasing rotavirus vaccine uptake: a randomised controlled trial

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

852

联系人通讯地址
临床试验信息
试验目的

1. To determine whether removal of financial barriers can increase uptake of rotavirus vaccine in children. 2. To determine whether provision of key information on rotavirus infection and vaccination can increase uptake of rotavirus vaccine in children.

试验分类
试验类型

随机平行对照

试验分期

其它

随机化

A study Research Assistant (RA) not involved with other follow-ups will randomly allocate all participants to either control or two intervention groups using block randomization with 1:1:1 ratio. Each group will have 217 participants.

盲法

Once the intervention has been allocated, this RA will not be blinded to participants group assignment, but the other RA conducting telephone interviews, investigators and participants will be blinded to participants group allocation.

试验项目经费来源

Health and Medical Research Fund (HMRF)

试验范围

/

目标入组人数

217

实际入组人数

/

第一例入组时间

2020-10-05

试验终止时间

2023-04-04

是否属于一致性

/

入选标准

(1) postpartum mothers from the study hospitals; (2) aged older than 18 years; (3) Cantonese speaking and able to read traditional Chinese; (4) have a plan to remain in Hong Kong with the infant after delivery for at least 8 months (upper age limit for giving rotavirus vaccine according to product information); (5) no obvious cognitive abnormality; (6) no serious obstetrical complications and baby is full-term (>=37 weeks of gestation) with no congenital abnormalities; and (7) can provide signed informed consent.;

排除标准

Subjects who cannot meet the inclusion criteria would be excluded.;

研究者信息
研究负责人姓名
试验机构

Nil

研究负责人电话
研究负责人邮箱
研究负责人邮编

852

联系人通讯地址
<END>

Nil的其他临床试验

香港中文大學的其他临床试验

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品

同适应症药物临床试验